Doyle John Brendan 4
4 · COGNITION THERAPEUTICS INC · Filed Dec 22, 2025
Insider Transaction Report
Form 4
Doyle John Brendan
Chief Financial Officer
Transactions
- Award
Common Stock
2025-12-18+30,000→ 455,350 total - Tax Payment
Common Stock
2025-12-18$1.50/sh−9,360$14,040→ 445,990 total
Footnotes (2)
- [F1]Shares earned upon the vesting of performance stock units ("PSUs") granted to the Reporting Person on February 14, 2024. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of certain performance goals. The remaining 50% of the total number of shares subject to the PSUs vested on December 18, 2025.
- [F2]Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of PSUs.